Update on child and adolescent immunizations: selected review of US recommendations and literature

Jenna A Katz1, Tali Capua, Joseph A Bocchini

  • 1Division of General Pediatrics, Cohen Children's Medical Center, North Shore-Long Island Jewish Health System, New Hyde Park, New York, USA.

Insights

Updated guidelines and research on childhood immunizations enhance vaccine safety and efficacy. Ensuring all children receive recommended vaccinations is crucial for preventing serious diseases.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Childhood vaccinations significantly reduce pediatric morbidity and mortality in the USA.
  • Recent research focuses on improving existing vaccines and developing new ones for enhanced protection.
  • Vaccination recommendations are expanding to include more subpopulations due to proven safety and efficacy.

Purpose of the Study:

  • To present a clinically relevant overview of recent research findings on child and adolescent immunizations.
  • To summarize updated guidelines from the American Academy of Pediatrics and the Advisory Committee on Immunization Practices.
  • To explore the relationship between febrile seizures and childhood immunizations.

Main Methods:

  • Review of selected recent publications on key vaccines.
  • Analysis of updated immunization guidelines.
  • Exploration of vaccine safety and efficacy data.

Main Results:

  • Vaccine improvements focus on safety, efficacy, and immunogenicity for better child protection.
  • Expanded recommendations cover influenza, HPV, DTaP, meningococcal, and pneumococcal vaccines.
  • Research continues to ensure all eligible children receive necessary vaccinations.

Conclusions:

  • Ongoing research in childhood and adolescent vaccinations will guide future recommendations.
  • Findings help optimize protection against serious diseases for all children and adolescents.
  • Continued efforts are needed to ensure universal vaccine uptake.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Vaccinations01:51

Vaccinations

Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...